CAESAREA, Israel, May 19, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive ...

Collaboration Will Endeavor to Reach Millions Suffering from Undiagnosed and Untreated Sleep Apnea Sufferers CAESAREA, Israel and PETERBOROUGH, N.H., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Itamar Medical ...

CHELMSFORD, Mass.--(BUSINESS WIRE)-- ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that it has successfully ...

Israeli sleep apnea company Itamar Medical announced today it’s broadening the capabilities of its at-home sleep apnea diagnostic testing line, WatchPAT. The WatchPAT system attaches to a user’s index ...

A public company with a sub-$1 billion market cap, struggles to get investors’ attention. To exceed that threshold, the CEO must grow the company’s top line faster than 30% without consuming too much ...

Itamar Medical to offer an integrated model of products and services. For the first time, the company will manage and coordinate all stages of diagnosis and treatment for hospitals In light of the ...

The price tag of Zoll Medical's proposed acquisition reflects a premium of 50% over Itamar's share price as of the market close on Friday. Today's big move for the healthcare stock is only slightly ...

Two additional published studies highlight WatchPAT’s accuracy and effectiveness in patients with Central Sleep Apnea (CSA) and Chronic Obstructive Pulmonary Disease (COPD) CAESAREA, Israel, Feb. 18, ...

Preliminary total revenue for the first quarter of 2020 is expected to be $8.4 to $8.6 million, an increase of 40% to 42% compared to the same period in 2019. The growth in revenue was primarily ...

Asahi Kasei's Zoll Medical unit plans to buy Itamar Medical for $538 million. Itamar's sleep disorder device appears to be a good fit for Zoll Medical's product lineup. While the deal is obviously ...